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ABSTRACT: Multivalent receptor-mediated interactions between
virions and a lipid membrane can be weakened using competitive
nonpathogenic ligand binding. In particular, the subsequent binding of
such ligands can induce detachment of bound virions, a phenomenon
of crucial relevance for the development of new antiviral drugs.
Focusing on the simian virus 40 (SV40) and recombinant cholera
toxin B subunit (rCTB), and using (monosialotetrahexosyl)ganglioside
(GM1) as their common receptor in a supported lipid bilayer (SLB),
we present the ﬁrst detailed investigation of this phenomenon by
employing the quartz crystal microbalance with dissipation (QCM-D)
and total internal reﬂection ﬂuorescence (TIRF) microscopy assisted 2D single particle tracking (SPT) techniques. Analysis of
the QCM-D-measured release kinetics made it possible to determine the binding strength of a single SV40−GM1 pair. The
release dynamics of SV40, monitored by SPT, revealed that a notable fraction of SV40 becomes mobile just before the release,
allowing to estimate the distribution of SV40-bound GM1 receptors just prior to release.
■ INTRODUCTION
Prior to internalization and infection, virions ﬁrst bind to
speciﬁc receptors present on the external lipid membrane of
their host cells. This process is controlled by the binding
strength of single ligand−receptor pairs/bonds, the number of
such pairs/bonds, and the ability to dynamically form and break
these bonds. Since the binding strength of individual ligand−
receptor pairs is often weak,1,2 establishment of multiple bonds
is typically required to obtain a suﬃcient residence time for
virus internalization to occur.3 The weak strength of the
individual ligand−receptor pairs implies that the lateral
interaction between them in solution is negligible, and
accordingly their formation and rupture occur nearly
independently or, in other words, in a sequential manner.
Such random transitions between “states” of diﬀerent under-
lying valencies can be described by the corresponding master
equations for the number of ligand−receptor pairs (see section
S4 in the Supporting Information and references therein) and
are known to inﬂuence the receptor distribution on the cell
membrane as well as the shape of membranes,3−8 factors that
are believed to be crucial also during the internalization process.
Insights regarding this as well as other multivalent biomolecular
interactions can be gained by directly probing the kinetics of
binding to cell membranes and mimics thereof9−12 or by
titration studies with suspended binders displaying diﬀerent
valencies.1,4 Information on interaction kinetics can also be
gained by time-resolved imaging of how single lipid vesicles
transiently interact with surface-immobilized virions.9 However,
the strong (power-law) dependence of the residence time on
the number of ligand−receptor pairs makes the binding
become irreversible already for a few bonds. High-resolution
microscopy was therefore mostly used to track the spatial
mobility of individual virus particles, thereby yielding
information about their diﬀusivity which is determined by
their multivalent interaction.13−15
A key motivation behind the above-mentioned basic studies
aimed at unraveling the nature of the interaction between
virions and a lipid membrane is to gain insights that can aid in
the development of antiviral therapies. Numerous related
applied studies were focused on attachment of inhibitors
targeting the receptor-binding sites of (suspended or
membrane-bound) virions,16−21 but the success of this
approach in terms of approved drugs has been limited. An
alternative stratergy is to target inhibitors toward the cellular
receptors, thereby preventing attachment of virions to cell
membranes.22−28 Despite fewer studies the latter approach has
indeed oﬀered a clinically used HIV antiviral, Maraviroc, which
interacts with the cellular coreceptor CCR5, thereby inhibiting
viral entry.29 Most of the corresponding assays22,23,25,28 were
measured at steady-state conditions and various mechanistic
aspects of the inhibition kinetics,26,27 such as inhibitor-induced
transient changes in the interaction proﬁle could therefore not
be characterized. One interesting aspect of such kinetics, related
to multivalency, is that in the course of inhibitor attachment the
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concentration of free receptors in a lipid membrane becomes
reduced, and as a consequence, the number of receptor−ligand
pairs for already bound virions may also decline, which will
eventually result in detachment of these virions. Herein, we
present what to our knowledge is the ﬁrst study of this
category.
As a model system to evaluate what type of information one
can gain by measuring virus release induced by a competitive
binder, we investigate how the addition of cholera toxin (CT)
inﬂuences the release kinetics of simian virus (SV40) being
prebound to a supported lipid bilayer (SLB) containing the
glycosphingolipid (GSL) GM1, having the shared feature of
being a receptor for both CT and SV40.5,30 As a model for
SV40 we used a virus-like particle (VLP), which is a
recombinant capsid containing 72 copies of the GM1-binding
subunit VP1, known to display very similar binding behavior as
native virions.5 To compete with the binding of SV40 to
membrane-embedded GM1, we used the recombinantly
expressed B subunit of cholera toxin (rCTB), which is
responsible for the receptor binding and intracellular traﬁcking
of the toxin.31 rCTB forms a pentameric structure with a
diameter around 6 nm,30 whereas the 72 pentameric VP1 units
of the SV40 capsid form a symmetric spherical particle with a
diameter of around 40 nm.32 Despite lack of sequence
homology, the structure of the VP1 pentamers making up
SV40 is very similar to the rCTB pentamer, each presenting ﬁve
GM1 binding sites positioned with a distance of 3 nm between
each other.33 The equilibrium dissociation constant of the
monovalent interaction of single GM1 entities with these
pentamers was previously determined using isothermal titration
calorimetry to be on the order of a few mM for VP1 of SV401
and as low as 40 nM for CTB,34 corresponding to Gibbs free
energies of around 6kBT and 17kBT, respectively. This
signiﬁcantly higher aﬃnity between GM1 and rCTB compared
to the interaction of GM1 with SV40, together with the positive
cooperativity previously suggested for binding of the rCTB
pentamer to multiple membrane-bound GM17,35 and its
structural similarity with the VP1 pentamers, makes rCTB a
suitable model compound to explore in the context of GM1-
mediated competitive binding with SV40 to a lipid membrane.
Quartz crystal microbalance with dissipation (QCM-D)
monitoring was employed to follow rCTB-induced release
kinetics of SV40 prebound to a SLB containing diﬀerent GM1
concentrations, which combined with a kinetic model
describing the multivalent SV40-GM1 and rCTB-GM1
interactions enabled an estimation of the strength of the
former interaction when approaching a single bond. Comple-
mentary total internal reﬂection ﬂuorescence (TIRF) micros-
copy experiments were focused on the inﬂuence of rCTB
binding on the mobility of individual SV40 particles and aimed
at determining the dynamic variation in number of receptors
engaged in the binding during the release process. The results
are conceptually valid in the broad context of GSLs and
glycoconjugates being utilized as receptors by a large number of
virions, such as polyomavirus, norovirus, rotavirus, parvovirus,
and inﬂuenza virus36−38 as well as bacterial toxins and
endogeneous lectins.37,39 This suggests in turn that the
experimental and theoretical approach presented in this work
will be generally applicable to unravel new insights regarding
multivalent interactions for many diﬀerent biological systems,
thereby both aiding a fundamental understanding of virus−
receptor interactions and oﬀering an analytical foundation for
the development of compounds aimed to inhibit virus
infections by interfering with cell-surface receptors rather
than the virus particles themselves.
■ RESULTS AND DISCUSSION
Release of Bound VLP by Subsequent rCTB Binding.
SLBs with a total GM1 content ranging from 0.05 and 2 wt %
(which translates to 0.03 to 1.3 mol %) were formed by
exposure of a silica-coated QCM-D crystal (placed in a
cylindrical measurement cell with a diameter of ∼10 mm and
height of ∼0.1 mm connected to a liquid handling system with
a length of ∼120 mm and diameter of ∼1 mm) to a mixture of
vesicles made of pure 1-palmitoyl-2-oleoyl-sn-glycero-3-phos-
phocholine (POPC) lipids and vesicles made of POPC and 5
wt % GM1 lipids (see section S1 C in the Supporting
Information for the details of controlling the GM1 content in
SLB). At 2 wt % GM1, vesicle binding and subsequent rupture
resulted in changes in resonance frequency, f, and energy
dissipation, D, of −27 Hz and 0.2 × 10−6, respectively (Figure
1), in agreement with previous studies of SLB formation at
these conditions.40 Subsequent binding of SV40 was performed
by exposing the GM1-containing SLB to a SV40 suspension
(0.139 nM) for 20 min at a ﬂow rate of 50 μL/min, resulting in
additional changes in f and D of −28 Hz and 4.2 × 10−6,
respectively (Figure 1). This frequency shift is far from
saturation, which was previously shown to correspond to
around −85 Hz using a higher SV40 concentration.8
Subsequent addition of rCTB (3.45 nM) at the same ﬂow
conditions resulted in an initial decrease in f (mass uptake)
which was followed by a dramatic increase (mass loss) that
saturated at −10 Hz (compared to the value corresponding to
the original SLB) and a signiﬁcant drop in D that saturated at a
value (0.1 ± 0.2) × 10−6. The values measured after saturated
binding of rCTB to a SV40-coated SLBs at diﬀerent GM1
coverages (Figure 2a) agree very well with the saturated shifts
observed upon addition of rCTB to SLBs containing
corresponding GM1 coverages but no SV40 (Figure S1),
Figure 1. Time trace of QCM-D response (ﬁfth overtone) upon SV40
and subsequent rCTB binding on a supported lipid bilayer (SLB) with
2 wt % GM1. The solid and dotted lines correspond to the frequency
and dissipation shifts. The measurements were performed by
subsequently exposing the SLB with solutions of 0.139 nM SV40,
buﬀer, and 3.45 nM rCTB at a ﬂow rate of 50 μL/min. Arrows indicate
the starting moments of solution exchange. Schematics of SLB with
GM1, SV40 binding on the SLB, and ﬁnally rCTB binding followed by
SV40 release are presented for better visualization of the competitive
binding system. No binding was observed to bare POPC SLBs (data
not shown).
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demonstrating that rCTB eﬃciently replaces SV40 from the
SLB.
The rate of binding (−dΔf/dt) of SV40 was observed to be
nearly constant above and decrease dramatically below 0.25 wt
% GM1 (Figure 2a,b) and displayed a nonlinear dependence on
GM1 coverage.
This suggests that SV40 binding under these conditions is
controlled globally by diﬀusion down to a GM1 content of
∼0.25 wt %, below which it becomes kinetically limited. The
dramatic increase in the rate of binding between 0.05 and 0.25
wt % further suggests that the formation of the ﬁrst bond is not
suﬃcient for the transition to the fully bound state; i.e., the
rupture of the ﬁrst bond just after its formation is more
probable than the formation of a few additional bonds needed
for ﬁrm binding. In other words, this means that the binding
process is limited by the sequential formation of the ﬁrst two or
three bonds (accurate evaluation of this number is beyond our
present goals although in principle it is possible via additional
experiments and detailed simulations8). This interpretation is
supported by detectable release of SV40 upon rinsing with
buﬀer at GM1 coverages of 0.05 and 0.1 wt %, while the
binding was essentially irreversible at high GM1 coverage.
Inspecting the kinetics during the competitive phase
indicates that the rate of rCTB-induced SV40 release increased
with decreasing GM1 content in the SLB (Figure 2a). In
particular, the SV40 release at 0.05 wt % GM1 occurs within
the time of solution exchange in the QCM-D cell (∼60 s),
while it takes several tens of minutes at 2 wt % GM1. The
strong dependence of SV40 release kinetics on GM1 coverage
cannot be attributed to a corresponding dependence of the rate
of rCTB binding on GM1 coverage, which was in fact constant
in this GM1 regime (Figure S1). A more plausible
interpretation is thus that the binding avidity of SV40 decreases
with decreasing GM1 content in SLB, indicating a smaller
number of SV40−GM1 bonds at lower GM1 content.
Deconvolution of the Measured Frequency Response.
To analyze rCTB-induced release kinetics of SV40 in further
detail, one may note that both rCTB and SV40 contribute to
Δf, while ΔD induced upon rCTB binding is negligible
compared to that induced upon SV40 binding (Figure 1 and
Figure S1). This makes it possible to deconvolute the measured
(total) Δf time trace into separate time traces for SV40
(Δf SV40) and rCTB (Δf rCTB), as shown e.g. in Figure 3a (see
section S2 C in the Supporting Information for more
information). This treatment of the data illustrates that SV40
release starts when the binding of rCTB approaches saturation
(∼−10 Hz), a behavior that was observed irrespective of GM1
Figure 2. (a) QCM-D time trace of SV40 and subsequent rCTB
binding on SLBs with diﬀerent GM1 concentrations (0.05−2 wt %)
under bindng conditions that were otherwise the same as in Figure 1.
The data are presented with an oﬀset at the injection of the SV40
suspension. (b) Rate of frequency change upon SV40 binding versus
the GM1 concentration in SLB. The error bars represent standard
deviation of mean values determined from at least three data sets.
Figure 3. (a) Deconvolution of the measured frequency time trace at 2
wt % GM1 in SLB: deconvoluted SV40 response (red line),
deconvoluted rCTB response (blue line), measured dissipation
response (dashed line). The SV40 release kinetics was essentially
linear within the time interval Δtrelease (highlighted by the rectangle).
(b) Inverse of the release time, Δtrelease, decreases monotonously with
increasing GM1 concentration in SLB and 1/Δtrelease approximately
yields a release rate constant kd. The error bars represent standard
deviation of mean values determined from at least three data sets.
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content. This thus demonstrates that SV40 release does not
start until a majority of GM1 lipids are engaged in binding of
rCTB; i.e., SV40 remains attached and is detected by QCM-D
up to the stage when it has only a few (as already noted in the
context of adsorption kinetics) or even a single (last) bond.
Quantiﬁcation of the Binding Energy of VLP to GM1.
For a more quantitative analysis of the release kinetics it is
crucial to determine the surface coverage of GM1, SV40, and
rCTB. The lipid membrane area corresponding to each GM1 is
∼1 nm2, and the extension of its hydrophilic headgroup above
the SLB is ∼1 nm.41 With an average radius of SV40 of 20 nm
(Figure S3) and under the assumption that the SLB is nearly
ﬂat (this assumption appears to be reasonable because the
membrane−support interaction is expected to prevent
appreciable deformation of the SLB), an area of 125 nm2 of
each SV40 can be reached by GM1, which corresponds to
around 10 capsid proteins (VP1) of SV40 as detailed in section
S4A of the Supporting Information (for virus binding to cells or
giant vesicles, this number may be appreciably larger due to
wrapping of a VLP or virion by the membrane5). Accordingly,
since each capsid protein can potentially bind to a single GM1,
a maximum of 10 GM1 (nSV40 = 10) can under these strict
assumptions be accommodated within the contact area of SV40
and a ﬂat SLB. From the diﬀerence in the measured frequency
shift of POPC + 2 wt % GM1 and a pure POPC SLBs, the
GM1 coverage, cGM1
0 , in each lipid layer of the SLB was
determined to be 1.8 × 10−2 nm−2 (here and below, “coverage”
and “surface concentration” are used interchangeably), which
matches well with previously reported estimates.7,40 Since a
conversion of Δf of QCM-D into coupled mass is not
straightforward due to the inﬂuence of hydrodynamically
coupled water to VLPs and rCTB,42 surface plasmon resonance
(SPR) was used to quantify the molecular mass uptake of SV40
and rCTB. With the latter technique, the surface coverage of
SV40, cSV40, was estimated to 2 × 10
−4 nm−2 at 2 wt % GM1
(Figure S2b in the Supporting Information). With 10 GMl per
SV40, the surface concentration of GM1 that is engaged in
SV40 binding, nSV40cSV40, thus becomes 2 × 10
−3 nm−2 at 2 wt
%, which is signiﬁcantly lower than the total GM1 coverage
(cGM1
0 = 1.8 × 10−2 nm−2). This means that the number of GM1
available for rCTB binding is essentially unaﬀected by the
precence of SV40, which is consistent with the observation of
nearly identical binding kinetics of rCTB in the presence
(Figure 3) and absence of SV40 (Figure S1). The saturated
surface coverage of rCTB at 2 wt % GM1 was estimated using
SPR to be 0.6 × 10−2 nm−2 (Figure S2a), yielding a rCTB to
GM1 ratio of 1:2.8. This ratio agrees well with previous reports
of the number of receptors bound per rCTB molecule below 5
mol % (7.5 wt %) GM1 in the SLB.40
The estimates above were made from pure stoichiometric
considerations, while in reality, the number of bonds that are
engaged in the binding also depends on the probability of single
bond formation. With cSV40/rCTB representing the surface
coverage of either SV40 or rCTB and cGM1
0 the total surface
coverage of GM1, the balanced condition for the surface
coverage of free/available GM1, cGM1, can be expressed as
+ + =c n P c n P c cMGM 1 SV40 SV40 SV40 rCTB rCTB rCTB GM10 (1)
where PSV40/rCTB is the probability that a given bond is formed
and nSV40/rCTB the maximum number of bonds that each
binding entity can form with GM1 lipids in the SLB (see
section S4A in the Supporting Information). At the competitive
conditions shown in Figures 2 and 3, the surface coverage of
rCTB determines cGM1, and the latter determines the SV40
binding strength or, in other words, detachment rate of bound
SV40. The formation and rupture of single SV40−GM1 and
rCTB−GM1 bonds resulting in their redistribution during
rCTB attachment are rapid because the binding energy of a
single ligand−receptor bond/pair is weak. Hence, we can
assume that the bond exchange is close to equilibrium and
accordingly the probability of SV40−GM1 and rCTB−GM1
bond formation can be described as (derivation in section S4D
in Supporting Information):
=
+
P
c
K cSV40/rCTB
GM1
SV40/rCTB GM1 (2)
with
= −−K a E k Texp( / )SV40/rCTB 1 SV40/rCTB B (3)
where ESV40/rCTB is the binding energy (Gibbs free energy for
dissociation) of a single GM1−ligand pair of the respective
particle and a = 1 nm−2 is the area comparable to the cross-
section area of a single GM1.
As noted above, the SV40 release was observed at the late
stage of the receptor redistribution, that is, when the rCTB
adsorption was close to saturation (Figure 3a). At this stage,
cGM1 available for SV40 binding is, as already noticed, controlled
by rCTB surface coverage and is according to the
stoichiometric considerations presented above, expected to be
appreciably smaller than cGM1
0 . Because of the low concentration
of unbound GM1 at this stage, the reattachment of SV40 can be
neglected, and the SV40 release kinetics can be represented as
(derivation in section S4D in the Supporting Information):
= −c
t
k c
d
d
SV40
d SV40 (4)
where
= − −k k P P(1 )nd d1 SV40 SV40 1SV40 (5)
is the eﬀective release rate constant, expressed via PSV40 and the
rate constant, kd1, of the rupture of the last bond accompanied
by SV40 release. In this context, we repeat (cf. the
Introduction) that the events of formation and rupture of
SV40−GM1 bonds are sequential, and accordingly SV40
release occurs only after rupture of the last bond, although
the sequential rupture of the last bonds may be below the
acquisition rate of the measurements. Equation 5 is derived
assuming that the redistribution of the number of bonds for
each SV40 is close to equilibrium even for the last bond. In
reality, due to SV40 detachment, the probability to have 1 or 2
bonds may be lower than that at equilibrium. The
corresponding (cumbersome) modiﬁcations of the theoretical
model are, however, not signiﬁcant for our analysis and
estimates.
In eq 5 the dependence of kd on PSV40 is strong because nSV40
is relatively large. During the SV40 release, as already noticed,
PSV40 is controlled primarily by the surface coverage of rCTB
and is almost constant because this phase is relatively short and
crCTB was nearly constant over the release kinetics (Δf rCTB in
Figure 3a). Under such circumstances, the release kinetics can
be characterized by an eﬀective ﬁrst-order release rate constant
which can be identiﬁed with kd (eq 5). At 2 wt % GM1, we have
kd = 0.05 min
−1 (Figure 2b). Using for this rate constant eq 5 in
combination with eq 2 and employing nSV40 = 10 (estimated in
section S4A of the Supporting Information), kd1 = 10
8 s−1
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(estimated in section S4D of the Supporting Information), and
cGM1 = 0.1cGM1
0 = 1.8 × 10−3 nm−2 (estimated taking into
account that release occurs at the late stage of rCTB binding
where cGM1 ≪ cGM10 ), one obtains PSV40 = 0.945, KSV40 = 1.0 ×
10−4 nm−2, and ESV40 = 9.2kBT = 22.3 kJ/mol. Note that
quantitative estimates of this type at low GM1 content (<0.5 wt
%) are not reliable because the assumption that cGM1 is constant
over the release kinetics does not appear to be valid (Figure
S4).
The maximum possible number of the SV40−GM1 bonds,
nSV40, is the most crucial parameter in our estimation of PSV40
and therefore ESV40 as well. Our estimate of this number, nSV40
= 10 (section S4A in the Supporting Information), is based on
the assumption that the SLB is perfectly ﬂat. However, during
the contact with SV40, the SLB can be locally deformed, and
accordingly nSV40 may be larger than 10. In particular,
Szklarczyk et al.8 recently reported that nSV40 may be as high
as 40. Repeating our estimates with the latter value of nSV40, we
obtain PSV40 = 0.488, KSV40 = 1.9 × 10
−3 nm−2, and ESV40 =
6.3kBT = 15.6 kJ/mol. With the binding energies ESV40 = 22.3
and 15.6 kJ/mol obtained here for nSV40 = 10 and nSV40 = 40,
the corresponding monovalent GM1−SV40 dissociation
constant becomes 0.1 and 2 mM, respectively. These numbers
are in reasonable agreement with values reported for the
monovalent interaction of GM1 with suspended SV40 (1−5
mM)1 but also illustrate the importance of being able to
accurately estimate nSV40.
Mobility Determination from TIRFM Assay. To analyze
the rCTB−SV40 competition process in further detail and,
more speciﬁcally, to gain additional information regarding the
number of engaged GM1 linkers to SV40, we complemented
the ensemble-averaged QCM-D measurements by SPT analysis
of individual SV40 VLPs bound to a GM1-containing SLB
(Figure 4). The SV40 VLPs were marked by dye-labeled
vesicles containing 5 wt % GM1, which is much higher than the
highest GM1 concentration used for SLB formation. As the
release rate strongly decreases with increasing GM1 concen-
tration (Figure 3b), this ensured ﬁrm vesicle-SV40 linking even
under competition conditions (because the rate of SV40 release
from the SLB was signiﬁcantly higher than the release rate of
dye-labeled vesicles from SV40 VLPs). The average diameter of
the dye-labeled vesicles (90 nm) was not considerably larger
than that of the VLPs (40 nm) which together with the low
VLP coverage ensured attachment of single vesicle to single
VLP and thereby qualiﬁes the criteria of single VLP detection.9
SV40 attachment and release (Figure 4, from left to right) were
monitored by TIRFM (see Movie S1), allowing to extract
single virion trajectories until release of the tracked virion
occurred (see Figure 4, insets, for representative trajectories).
Interestingly, for a GM1 concentration of 0.25 wt % in the
SLB, all SV40 VLPs were essentially immobile directly after
attachment (showing an apparent diﬀusion coeﬃcient D of
0.002 μm2/s, attributed to originate primarily from localization
noise during the tracking process). However, after a lag time of
rCTB addition we observed four diﬀerent types of trajectories
(Figure 5a): (i) VLPs that remained immobile directly prior to
release, (ii) VLPs that became mobile prior to release, (iii)
VLPs that became mobile, but turned immobile again and
showed no release, and (iv) VLPs that remained immobile
during the whole TIRF measurement, showing no release at all.
These remarkable observations indicate that the SV40 release
process is more complex than suggested by QCM-D (providing
ensemble-averaged results) and that interaction with rCTB
does not necessarily result in direct release of all bound SV40
(see case (iii) in Figure 5a). To better understand the observed
SPT dynamics and its relation to the ensemble-averaged
kinetics, we calculated the temporal change of the number of
bound SV40 VLPs, which showed (after a short lag period) a
sharp decrease followed by a slow transition to a constant SV40
coverage (Figure 5b, black line). A direct comparison with the
QCM-D results (Figure 5b, red line), obtained using the same
GM1 content in the SLB and rCTB concentration, shows good
agreement of the release dynamics for both complementary
approaches, conﬁrming our previous interpretation of the
QCM-D data. In particular, the fraction of VLPs which do not
detach in the SPT analysis, and which could not be accurately
determined from the QCM-D analysis, is relatively small
(∼8%), and their presence is not crucial for the analysis of the
ensemble-averaged kinetics.
In a next step, we determined the D distributions of SV40
VLPs directly after injection of rCTB and prior to release of the
VLPs (Figure 5c) by calculating for each observed SV40
trajectory the D value from the data of the ﬁrst 10 s after rCTB
addition or of the trajectory’s last 10 s, respectively, and by
ﬁnally compiling all these D values into histograms. Directly
after rCTB injection, most of the SV40 VLPs are immobile,
indicated by a single peak at 0.002 μm2/s (log D = −2.7) in the
respective D histogram (Figure 5c), which is attributed to
localization noise and marks the lower resolution limit in D
determination. Prior to the release, a mobile peak appears at 0.1
μm2/s (log D = −1) in addition to the immobile peak,
indicating that approximately 25% of the VLPs become mobile
(due to rCTB competition lowering the number of SV40−
GM1 bonds) before releasing, while approximately 75% of the
VLPs appear to release directly from an immobile state.
The coeﬃcient of diﬀusion of SV40 VLPs, which become
mobile after rCTB addition, depends on the number of bound
GM1 receptors, n, at a particular time. Our recent experimental
studies13 of a similar system (receptor-limited diﬀusion of lipid
vesicles) indicate that the corresponding dependence is
expected to be D = DGM1/n, where DGM1 is the diﬀusion
coeﬃcient of a single GM1 receptor, and accordingly we have
=n D D/GM1 (6)
Figure 4. Illustration of tracking (SPT) measurements of individual
SV40 VLPs using TIRF microscopy upon competitive binding induced
by rCTB (illustration not to the scale). The dimension of each
micrograph is 50 μm × 50 μm.
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Using this expression and taking into account that DGM1 is in
the range between 0.8 and 1.8 μm2/s,8,43 we roughly estimated
the distribution of the number of GM1 receptors bound to
SV40 VLPs directly prior to release (Figure 5d, using average
DGM1 = 1.3 μm
2/s). This distribution is skewed and relatively
wide with a peak maxima around 6, which is close to our
geometric estimation of maximum number of contact points for
SV40 on a planar SLB (nSV40 = 10). However, it also exhibits a
tail with values n > 40, which can be explained by either local
SLB deformation upon VLP binding, local GM1 clustering into
domains, crowding eﬀects at high rCTB coverage, and/or
limitations of eq 6 for very high n. Still, these results,
supplemented with the literature, suggest that even at
competition the number of SV40−GM1 pair can be up to
40; therefore, prior to competition it is likely to be 40 or more,
thus rendering the VLPs immobile, and yields a value of the
dissociation constant for the monovalent interaction (>2 mM)
in agreement with previous estimates.1 More interestingly, a
sharp cutoﬀ at n = 3 is observed, indicating that with our
temporal resolution the SV40 binding can be tracked down to
this low n value. This cutoﬀ value matches well with the
theoretical estimation8 of minimum number of SV40−GM1
contacts required for detecting SV40 with our temporal
resolution, while analysis of VLPs with n < 3 (D > 0.4 μm2/
s) would require higher acquisition rates.
■ CONCLUSIONS
We can summarize our key ﬁndings as follows:
First, we observed and scrutinized competitive binding of
rCTB and SV40 toward their common receptor, i.e., GM1 on
cell membrane mimics using QCM-D. Because of the higher
aﬃnity of rCTB to GM1, its attachment results in redistribution
of GM1 bound to rCTB and SV40 with subsequent release of
SV40. This process was interpreted by using a theoretical
model to determine the binding aﬃnity of SV40 from its release
kinetics, yielding values matching previous estimates using
monovalent binders.
Second, our SPT analysis conﬁrms and extends the
ensemble-averaged QCM-D data. In particular, it explicitly
shows that the attachment of rCTB induces 2D diﬀusion of
SV40 prior to release (the diﬀusion coeﬃcient increases by 5-
to 150-fold), while a small fraction of SV40 does not release. In
addition, the SPT analysis allows us to conclude that the bound
SV40 can be observed even if the number of the SV40−GM1
bonds is reduced down to 3, which in agreement with a recent
modeling approach of the SV40−GM1 interaction.8 All these
Figure 5. Mobility of SV40 VLPs changes due to competition with rCTB. (a) Four diﬀerent modes [(i)−(iv)] of SV40 movement were observed
using SPT (and further described in the text). The minimum and maximum values of the respective diﬀusion coeﬃcient are employed to designate
the color gradient from cyan to magenta for each track. (b) SV40 coverage (determined using TIRFM, black, and QCM-D, red) in dependence of
the observation time (after injecting rCTB). Note that the SV40 concentration during VLP incubation diﬀers between both techniques (0.006 95 nM
in TIRFM versus 0.139 nM in QCM-D), while SLB GM1 concentration (0.25 wt %) and rCTB concentration (34.5 nM) are the same in both cases.
The shorter lag time in QCM-D data than in TIRF data is due to ﬂow vs stagnant condition in the respective experimental setup. (c) Distribution of
diﬀusion coeﬃcient, D, of SV40 VLPs directly after rCTB injection and prior to the release of the VLPs triggered by competition with injected rCTB,
which is converted into (d) the number of bonds formed between SV40 VLPs and GM1 receptors in the SLB prior to release as estimated by using
eq 6 with DGM1 = 1.3 μm
2/s. Here we show the DGM1/D distribution only for n < 50, although it exhibits a small tail beyond this value. This was
motivated by the observation that the mobile and immobile peaks start to overlap in this region, which introduces a notable bias for DGM1/D
exceeding 50.
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SPT results are inherently related to the rCTB and SV40
competition for receptors because the dynamics of SV4015 and
many other viruses on cell membrane mimics under other
conditions are typically too slow to be tracked using traditional
microscopes.14,15 Further, attempts to lower the receptor
concentration for SPT measurements down to that correspond-
ing to the regime where mobility should be observed typically
result in too weak aﬃnity to enable suﬃcient statistics.
Therefore, our SPT setup is an unique approach to quickly
follow the complex binding−unbinding dynamics of viruses on
cell mimics or membranes and even to detect or further modify
the receptor distribution speciﬁcally on cell membranes.
Finally, we note that the competition between virions and
inhibitors (ligands) for receptors like we observed and
scrutinized in our study can potentially be used in application
related to antiviral therapies. In real systems an additional
challenge of this lectin-based competitive approach will be
cellular internalization of the inhibitor (ligand)−receptor
complex, which is likely to replenish the receptors on cell
surfaces, although both internalization44 and receptor regener-
ation45,46 processes are slow on the time scale of the kinetics of
our system. The potential solution of this problem can be the
design of inhibitors with no or slow internalization, such as
mutated ligands with lower valency or greater distance between
their binding sites than that of the wild types.4,47
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